An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Saved in:
| Title: | An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol. |
|---|---|
| Authors: | Randremanana RV; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Raberahona M; Centre d'Infectiologie Charles Mérieux, University of Antananarivo, Antananarivo, Madagascar.; Department of Infectious Diseases, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar., de Dieu Randria MJ; Department of Infectious Diseases, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.; Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar., Bourner J; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK. josephine.bourner@ndm.ox.ac.uk., Zadonirina G; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Razananaivo H; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Mayouya-Gamana T; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Mangahasimbola R; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Pesonel E; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Gillesen A; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Rajerison M; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Andrianaivoarimanana V; Institut Pasteur de Madagascar, Antananarivo, Madagascar., Edwards T; London School of Hygiene and Tropical Medicine, London, UK., Horby P; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK., Olliaro P; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK. |
| Source: | Trials [Trials] 2024 Jul 05; Vol. 25 (1), pp. 457. Date of Electronic Publication: 2024 Jul 05. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38970065 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Randremanana+RV%22">Randremanana RV</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Raberahona+M%22">Raberahona M</searchLink>; Centre d'Infectiologie Charles Mérieux, University of Antananarivo, Antananarivo, Madagascar.; Department of Infectious Diseases, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22de+Dieu+Randria+MJ%22">de Dieu Randria MJ</searchLink>; Department of Infectious Diseases, University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.; Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Bourner+J%22">Bourner J</searchLink>; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK. josephine.bourner@ndm.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Zadonirina+G%22">Zadonirina G</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Razananaivo+H%22">Razananaivo H</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Mayouya-Gamana+T%22">Mayouya-Gamana T</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Mangahasimbola+R%22">Mangahasimbola R</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Pesonel+E%22">Pesonel E</searchLink>; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gillesen+A%22">Gillesen A</searchLink>; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Rajerison+M%22">Rajerison M</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Andrianaivoarimanana+V%22">Andrianaivoarimanana V</searchLink>; Institut Pasteur de Madagascar, Antananarivo, Madagascar.<br /><searchLink fieldCode="AU" term="%22Edwards+T%22">Edwards T</searchLink>; London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Horby+P%22">Horby P</searchLink>; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Olliaro+P%22">Olliaro P</searchLink>; ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101263253%22">Trials</searchLink> [Trials] 2024 Jul 05; Vol. 25 (1), pp. 457. <i>Date of Electronic Publication: </i>2024 Jul 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial Protocol; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101263253 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217456215%22">17456215 </searchLink><i>NLM ISO Abbreviation: </i>Trials <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38970065 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13063-024-08302-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 457 Titles: – TitleFull: An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Randremanana RV – PersonEntity: Name: NameFull: Raberahona M – PersonEntity: Name: NameFull: de Dieu Randria MJ – PersonEntity: Name: NameFull: Bourner J – PersonEntity: Name: NameFull: Zadonirina G – PersonEntity: Name: NameFull: Razananaivo H – PersonEntity: Name: NameFull: Mayouya-Gamana T – PersonEntity: Name: NameFull: Mangahasimbola R – PersonEntity: Name: NameFull: Pesonel E – PersonEntity: Name: NameFull: Gillesen A – PersonEntity: Name: NameFull: Rajerison M – PersonEntity: Name: NameFull: Andrianaivoarimanana V – PersonEntity: Name: NameFull: Edwards T – PersonEntity: Name: NameFull: Horby P – PersonEntity: Name: NameFull: Olliaro P IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 07 Text: 2024 Jul 05 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1745-6215 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Trials Type: main |
| ResultId | 1 |